Our results show that the specific markers of gastrointestinal tumors, including CDX2 and SATB2, were consistently negative in SRCC, while Villin or COX2 had positive expression levels in one case, so this indicator needs to be carefully considered in the differential diagnosis. Here, SATB2 is linked to digestive system neoplasm.